Nurse-led Integrated Care in COPD Patients With a Pulmonary Exacerbation

COPD Exacerbation Clinical Trial

— NICCO  

Official title:

Nurse-led Integrated Care to Improve Quality of Life in COPD Patients With a Pulmonary Exacerbation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04011332
• Other study ID #: 2019-00797
• Status: Completed
• Phase: N/A
• Start date: July 4, 2019
• Est. completion date: April 30, 2023

Study information

• Verified date: May 2023
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to evaluate the effect and effectiveness of the nurse-led integrated care programme for the management of COPD (Chronic Obstructive Pulmonary Disease) exacerbations on patients' quality of life, rehospitalisation and exacerbation rate, illness-related emotional distress, selected health behaviours and cost-utility at three months. Furthermore, understanding barriers and facilitators to implementation success is of interest.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 69
• Est. completion date: April 30, 2023
• Est. primary completion date: March 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients with a confirmed diagnosis of COPD (GOLD 1-4)

• Hospitalisation due to a COPD exacerbation and decision to start with steroids and/or antibiotics (severe exacerbation)

• Age = 18

Exclusion Criteria:

• Cognitive impairment (dementia, delirium)

• Not speaking German, French, Italian, English, Spanish, Portuguese, Serbian, Tamil, Hindi, Turkish or Slovakian

Related Conditions & MeSH terms

• COPD Exacerbation

Intervention

Other:
• Integrated Care Model
The patients who are hospitalised due to a COPD exacerbation will be aligned to a nurse-led integrated care model for three months. The model constitutes a bundle of interventions that are commonly known as key elements in COPD management. In addition, the ANP-Team (Advanced Nursing Practice-Team) will coordinate the different health professionals within the hospital and across transitions within the three months.

Locations

Country	Name	City	State
Switzerland	University Hospital Zurich	Zürich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in CRQ (Chronic Respiratory Questionnaire) scores	Change in the four CRQ (Chronic Respiratory Questionnaire) subscores from week 1 to 13. The self-administered questionnaire version with standardised dyspnea questions (SAS) will be used. The questionnaire was developed for patients with chronic airflow limitations and comprises 20 items which assess four domains: 1) dyspnea, 2) fatigue, 3) emotional function and 4) mastery. The scoring scale ranges from 1 (extreme) to 7 (not at all) and will be assessed with a recall period of the past 2 weeks. A subscore for each domain (sum of items / number of items) will be calculated.	at week one and week 13